Overview and Practical Application of Coagulation Assays in Managing Anticoagulation with Direct Oral Anticoagulants (DOACs)
- 24 August 2020
- journal article
- research article
- Published by Springer Nature in Current Pharmacology Reports
- Vol. 6 (5) , 241-259
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross‐sectional pharmacodynamic study based on peak and trough plasma levelsJournal of Thrombosis and Haemostasis, 2013
- Unfractionated Heparin for the Treatment of Venous Thromboembolism: Best Practices and Areas of UncertaintySeminars in Thrombosis and Hemostasis, 2012
- Impact of dabigatran on a large panel of routine or specific coagulation assaysThrombosis and Haemostasis, 2012
- Monitoring direct thrombin inhibitors with a plasma diluted thrombin timeThrombosis and Haemostasis, 2007
- Phospholipid composition controls thromboplastin sensitivity to individual clotting factorsJournal of Thrombosis and Haemostasis, 2006
- Ecarin Chromogenic Assay – A New Method for Quantitative Determination of Direct Thrombin Inhibitors Like HirudinPathophysiology of Haemostasis and Thrombosis, 2003
- Inaccuracy of the ‘derived’ fibrinogen measurementBlood Coagulation & Fibrinolysis, 1994
- Chromogenic assay for the prothrombin activator ecarin from the venom of the saw-scaled viper (Echis carinatus)Toxicon, 1986
- ICSH/ICTH Recommendations for Reporting Prothrombin Time in Oral Anticoagulant ControlActa Haematologica, 1984
- New method for the rapid detection of vitamin K deficiencyClinica Chimica Acta, 1980